The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication-Reference-Cited by-同舟云学术

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication

Published:2017 Issue:11 Volume:56 Page:1277-1285
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Sue Soichiro¹,Kuwashima Hirofumi²,Iwata Yuri³,Oka Hiroyuki⁴,Arima Isao⁵,Fukuchi Takehide⁶,Sanga Katsuyuki⁷,Inokuchi Yasuhiro⁸,Ishii Yuniba⁹,Kanno Masatomo¹⁰,Terada Masahiro¹¹,Amano Hitoshi¹²,Naito Makoto²,Iwase Shigeru³,Okazaki Hiroshi⁴,Komatsu Kazuto⁵,Kokawa Atsushi⁶,Kawana Ichiro⁷,Morimoto Manabu⁸,Saito Toshifumi⁹,Kunishi Yosuke¹⁰,Ikeda Akihiko¹¹,Takahashi Daisuke¹²,Miwa Haruo⁶,Sasaki Tomohiko¹,Tamura Toshihide¹,Kondo Masaaki¹,Shibata Wataru¹³,Maeda Shin¹

Affiliation:

1. Department of Gastroenterology, Yokohama City University Graduate school of Medicine, Japan

2. Department of Gastroenterology, Yokohama Hodogaya Central Hospital, Japan

3. Department of Gastroenterology, Fujisawa City Hospital, Japan

4. Department of Gastroenterology, Yokohama Minami Kyousai Hospital, Japan

5. Department of Gastroenterology, Yokosuka City Hospital, Japan

6. Department of Gastroenterology, Yokohama City University Medical Center, Japan

7. Department of Gastroenterology, Saiseikai Yokohamashi Nanbu Hospital, Japan

8. Department of Gastroenterology, Kanagawa Cancer Center, Japan

9. Department of Gastroenterology, Yokohama Ekisaikai Hospital, Japan

10. Department of Gastroenterology, Kanagawa Prefectual Ashigarakami Hospital, Japan

11. Department of Gastroenterology, Japanese Red Cross Hadano Hospital, Japan

12. Department of Gastroenterology, Fujisawa Shounandai Hopsital, Japan

13. Advanced Medical Research Center, Yokohama City University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/11/56_56.7833/_pdf

Reference18 articles.

1. 1. Gonzalez CA, Megraud F, Buissonniere A, et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol 23: 1320-1324, 2012.

2. 2. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 104: 488-492, 2012.

3. 3. Greenberg ER, Park JY. Effectiveness of Helicobacter pylori eradication. In: Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer IARC Working Group Report Volume 8. International Agency for Research on Cancer. Albert Thomas, Lyon Cedex, 2014: 64-71.

4. 4. Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 12: CD008337, 2013.

5. 5. Asaka M, Sugiyama T, Kato M, et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 6: 254-261, 2001.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori;Journal of Clinical Medicine;2023-08-22

2. Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial;Chinese Medical Journal;2023-05-22

3. Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of Helicobacter pylori Infection;Annals of Pharmacotherapy;2023-01-23

4. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis;Therapeutic Advances in Gastroenterology;2023-01

5. Vonoprazan and high‐dose amoxicillin dual therapy for Helicobacter pylori first‐line eradication: A single‐arm, interventional study;JGH Open;2022-12-08